EUVIMEDObjevte EUVIMED
Crossref

Asiaticoside ameliorates DSS ‐induced colitis in mice by inhibiting inflammatory response, protecting intestinal barrier and regulating intestinal microecology

Kunjian Liu, Yu Yin, Chong Shi, Chengqiu Yan, Yiwen Zhang, Li Qiu, Shuangyan He, Guofeng Li iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8129 ↗

At a glance

Journal article in Phytotherapy Research, 2024. Written by Kunjian Liu and 7 co-authors. Institution: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Major MEDLINE topics: Colitis, Ulcerative, Colitis, Triterpenes. Cited 25 times so far (Crossref); 68 references. Funded by: Natural Science Foundation of Jilin Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Ulcerative colitis (UC) is one of the most prevalent inflammatory bowel diseases and poses a serious threat to human health. Currently, safe and effective preventive measures are unavailable. In this study, the protective effects of asiaticoside (AS) on dextran sodium sulfate (DSS)‐induced colitis in mice and the underlying molecular mechanism were investigated. In this experiment, colitis was induced in mice with DSS. Subsequently, the role of AS in colitis and its underlying mechanisms were examined using H&E staining, immunofluorescence staining, western blot, Elisa, FMT, and other assays. The results showed that AS significantly attenuated the related symptoms of DSS‐induced colitis in mice. In addition, AS inhibited the activation of signaling pathways TLR4/NF‐κB and MAPK reduced the release of inflammatory factors, thereby attenuating the inflammatory response in mice. AS administration also restored the permeability of the intestinal barrier by increasing the levels of tight junction‐associated proteins (claudin‐3, occludin, and ZO‐1). In addition, AS rebalanced the intestinal flora of DSS‐treated mice by increasing the diversity of the flora. AS can alleviate DSS‐induced ulcerative colitis in mice by maintaining the intestinal barrier, thus inhibiting the signaling pathways TLR4/NF‐κB and MAPK activation, reducing the release of inflammatory factors, and regulating intestinal microecology.

Subjects

MeSH terms (MEDLINE)

Colitis, UlcerativeColitisTriterpenesHumansAnimalsMiceNF-kappa BToll-Like Receptor 4Dextran SulfateMice, Inbred C57BLDisease Models, AnimalColon

Author keywords

asiaticosidecolitisintestinal barrierintestinal microflorasignaling pathways TLR4/NF‐κB and MAPK

Substances

asiaticosideNF-kappa BToll-Like Receptor 4Dextran SulfateTriterpenes

Authors and institutions

  • College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • Anorectal Department, First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
  • Anorectal Department, Shenzhen Bao'an Authentic TCM Therapy Hospital, Shenzhen, China.

ORCID profiles: Guofeng Li

Funding

  • Natural Science Foundation of Jilin Province

Cite

APA

Liu, K., Yin, Y., Shi, C., Yan, C., Zhang, Y., Qiu, L., He, S., & Li, G. (2024). Asiaticoside ameliorates DSS ‐induced colitis in mice by inhibiting inflammatory response, protecting intestinal barrier and regulating intestinal microecology. Phytotherapy Research. https://doi.org/10.1002/ptr.8129

Vancouver

Liu K, Yin Y, Shi C, Yan C, Zhang Y, Qiu L, et al. Asiaticoside ameliorates DSS ‐induced colitis in mice by inhibiting inflammatory response, protecting intestinal barrier and regulating intestinal microecology. Phytotherapy Research. 2024. doi:10.1002/ptr.8129

BibTeX
@article{Liu2024,
  author = {Liu, Kunjian and Yin, Yu and Shi, Chong and Yan, Chengqiu and Zhang, Yiwen and Qiu, Li and He, Shuangyan and Li, Guofeng},
  title = {Asiaticoside ameliorates DSS ‐induced colitis in mice by inhibiting inflammatory response, protecting intestinal barrier and regulating intestinal microecology},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8129}
}
Start for free →